Form 8-K - Current report:
SEC Accession No. 0001193125-25-082809
Filing Date
2025-04-16
Accepted
2025-04-16 16:15:39
Documents
14
Period of Report
2025-04-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d905282d8k.htm   iXBRL 8-K 47042
2 EX-3.1 d905282dex31.htm EX-3.1 140487
  Complete submission text file 0001193125-25-082809.txt   354494

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20250415.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20250415_lab.xml EX-101.LAB 18740
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20250415_pre.xml EX-101.PRE 11718
17 EXTRACTED XBRL INSTANCE DOCUMENT d905282d8k_htm.xml XML 3887
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 25843024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)